GSK acquires joint venture interest
Pharmaceuticals giant GlaxoSmithKline (GSK) has acquired the remaining shares that it did not already own of Shenzhen Neptunus Interlong Bio-Technique (Neptunus) for £24 million.
News
Pharmaceuticals giant GlaxoSmithKline (GSK) has acquired the remaining shares that it did not already own of Shenzhen Neptunus Interlong Bio-Technique (Neptunus) for £24 million.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software